Approval · Notice of Compliance 16428 · 2014
AMOXICILLIN: Notice of Compliance 16428
Issued December 10, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16428
- Date
- December 10, 2014
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Antibiotic
- Canadian reference product
- APO-AMOXI (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | 02434709 | Cancelled Pre Market |
| AMOXICILLIN | 02434717 | Cancelled Pre Market |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 250 MG per CAP
- AMOXICILLIN TRIHYDRATE 500 MG per CAP